semaglutide going off market DESTROYING DEMAND: Weight-loss drugs are crushing food demand as farmers face a growing surplus of stock they can't sell, resulting in thousands of tons of goods that could go bad. And it's Semaglutide Market Share, Size &

Dose escalation in the phase 3 trial is designed to reduce the incidence of gastrointestinal adverse events when switching to monthly dosing

It stands to reason that treating obesity might reduce an individuals risk of obesity-related cancer, and there are three broad categories of intentional weight loss strategies that could achieve this: bariatric surgery, behavioural intervention (including diet and exercise), and pharmacotherapy

More relevant to weight management, these agents act on receptors in the brain's appetite centers, particularly the hypothalamus, reducing hunger signals and increasing satiety after meals

Retatrutide is an investigational triple receptor agonist being studied for its potential role in weight management by influencing appetite, metabolism and energy balance